EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial

Tair Nurpeissov, Kairat Tabynov, Ainagul Zhubanturliyeva, Temyrzhan Nurpeissov, Viktoriya Khan, Olzhas Seidakhmetov, Baktygul Yessimova, Gulbanu Sarsenbayeva, Elmira Tailakova, Turlan Bolatbekov, Akbota Sergazina, Nazugum Akhtemova und 6 weitere

Allergology International · 2026-06

DOI: 10.1016/j.alit.2026.05.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergology International, 2026-06. Verfasst von Tair Nurpeissov und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Center Rakhat, Almaty, Kazakhstan; Department of General Immunology, Asfendiyarov Kazakh National Medical University (KazNMU), Almaty, Kazakh…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Allergen immunotherapyArtemisia vulgarisRecombinant allergenSubcutaneous immunotherapyUltra-short course

Autor:innen und Institutionen

  • Medical Center Rakhat, Almaty, Kazakhstan; Department of General Immunology, Asfendiyarov Kazakh National Medical University (KazNMU), Almaty, Kazakhstan.
  • International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU), Almaty, Kazakhstan; Laboratory of Preclinical and Experimental Studies, Kazakh National Agrarian Research University (KazNARU…
  • Medical Center Rakhat, Almaty, Kazakhstan.
  • International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU), Almaty, Kazakhstan.
  • Scientific Research Institute for Biological Safety Problems, Gvardeyskiy, Korday district, Zhambyl region, Kazakhstan.
  • OtarBioPharm LLP, Gvardeyskiy, Korday district, Zhambyl region, Kazakhstan.

Zitieren

APA

Nurpeissov, T., Tabynov, K., Zhubanturliyeva, A., Nurpeissov, T., Khan, V., Seidakhmetov, O., Yessimova, B., Sarsenbayeva, G., Tailakova, E., Bolatbekov, T., Sergazina, A., Akhtemova, N., Rakhmatullayeva, G., Yelchibayeva, L., Shorayeva, K., Yershebulov, Z., Petrovsky, N., & Tabynov, K. (2026). Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial. Allergology International. https://doi.org/10.1016/j.alit.2026.05.010

Vancouver

Nurpeissov T, Tabynov K, Zhubanturliyeva A, Nurpeissov T, Khan V, Seidakhmetov O, et al. Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial. Allergology International. 2026. doi:10.1016/j.alit.2026.05.010

BibTeX
@article{Nurpeissov2026,
  author = {Nurpeissov, Tair and Tabynov, Kairat and Zhubanturliyeva, Ainagul and Nurpeissov, Temyrzhan and Khan, Viktoriya and Seidakhmetov, Olzhas and Yessimova, Baktygul and Sarsenbayeva, Gulbanu and Tailakova, Elmira and Bolatbekov, Turlan and Sergazina, Akbota and Akhtemova, Nazugum and Rakhmatullayeva, Guliza and Yelchibayeva, Leila and Shorayeva, Kamshat and Yershebulov, Zakir and Petrovsky, Nikolai and Tabynov, Kaissar},
  title = {Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial},
  journal = {Allergology International},
  year = {2026},
  doi = {10.1016/j.alit.2026.05.010}
}
Kostenlos starten →